All Stories

  1. Constructs Influencing Patient Perceptions of Use of AI in Medical Imaging Analysis: Systematic Review
  2. Quality of life and patient-reported outcomes after non-surgical management of early-stage endometrial cancer and endometrial hyperplasia with atypia: a long-term follow-up of the feMMe Phase II randomized clinical trial
  3. Nevus clustering on the back associated with in situ melanoma in a Queensland melanoma high-risk cohort
  4. Evolving landscape of consumer‐based smartphone apps for skin cancer prevention and early detection
  5. Motivation-informed digital reminders were no more effective than standard reminders for trial task completion in a randomised Study Within A Trial (SWAT)
  6. Women’s lived experiences of being diagnosed with early-stage endometrial cancer and making treatment decisions: A systematic review and thematic synthesis
  7. Long-term oncological and reproductive outcomes following treatment with the levonorgestrel intrauterine device for endometrial hyperplasia and adenocarcinoma – Results from the feMMe phase 2 randomized clinical trial
  8. Psychological Wellbeing After a Diagnosis of Melanoma In Situ: A Qualitative Interview Study
  9. Constructs Influencing Patient Perceptions of Use of AI in Medical Imaging Analysis: Systematic Review (Preprint)
  10. Skin cancer awareness and sun protection advice for outdoor workers in Australia: Review of communication channels to optimise reach and relevance
  11. Automated classification of site-specific cutaneous photodamage using a convolutional neural network and 3D total body photography
  12. Exploring Melanoma Awareness in the Australian Adult Population: A Cross‐Sectional Survey
  13. 3D-total body photography identifies cutaneous phenotypes associated with late-onset invasive melanoma risk
  14. The Impact of Multidisciplinary Research on Progress in Skin Cancer Prevention
  15. Automating skin colour assessment using 3D total‐body photography: A proof‐of‐concept study
  16. An Overview of Data Analysis Approaches and Biases in Unveiling the Impact of COVID-19 on Melanoma Diagnosis
  17. A longitudinal dataset of tile and corresponding dermoscopic images with metadata for identifying skin cancers
  18. Practice Guidelines for Teledermatology in Australia: 2025 Update
  19. Three-Dimensional Total Body Photography Enables Automated Obesity-Related Comorbidity Screening in Dermatology
  20. Understanding Contemporary Endometrial Cancer Survivorship Issues: Umbrella Review and Healthcare Professional Survey
  21. Privacy in Imaging for Dermatology Research
  22. What Are Patients’ Perceptions and Attitudes Regarding the Use of Artificial Intelligence in Skin Cancer Screening and Diagnosis? Narrative Review
  23. Informing a Position Statement on the Use of Large Language Models and AI Scribes in Dermatology in Australia
  24. Unpredictable interdependence of invasive and in situ melanoma
  25. Attitudes Towards the Use of Artificial Intelligence in Dermatology: A Survey of Australian Dermatologists
  26. The deep imaging phenotype for melanoma risk stratification
  27. Estimation of Body Mass Index from 3-Dimensional Total Body Photography
  28. Exploring the Views of Dermatologists, General Practitioners, and Melanographers on the Use of AI Tools in the Context of Good Decision-Making When Detecting Melanoma: Qualitative Interview Study
  29. Combining Automated Lesion Risk and Change Assessment Improves Melanoma Detection: A Retrospective Accuracy Study
  30. Skin 2.0: How Cutaneous Digital Twins Could Reshape Dermatology
  31. The impact of surgical complications on obstetricians’ and gynecologists’ well-being and coping mechanisms as second victims
  32. Sun safe practice in the sport sector: industry forum report September 2025
  33. Incidence and patterns of newly developed pigmented lesions in adults at high risk for melanoma
  34. Automated Detection of Pigmented Iris Freckles Using a Deep Neural Network for Cutaneous Melanoma Risk
  35. Participant Motivators and Expectations in the MEL-SELF Randomized Clinical Trial of Patient-Led Surveillance for Recurrent Melanoma: Content Analysis of Survey Responses
  36. Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study
  37. Targeted Screening for Cancer: Learnings and Applicability to Melanoma: A Scoping Review
  38. Comparison of artificial intelligence smartphone applications for skin cancer risk stratification of pigmented lesions: An observational study
  39. Protocol for the process evaluation of the GOAL trial: investigating how comprehensive geriatric assessment (CGA) improves patient-centred goal attainment in older adults with chronic kidney disease in the outpatient setting
  40. Exploring the Views of Dermatologists, General Practitioners, and Melanographers on the Use of AI Tools in the Context of Good Decision-Making When Detecting Melanoma: Qualitative Interview Study (Preprint)
  41. A Narrative Review: Opportunities and Challenges in Artificial Intelligence Skin Image Analyses Using Total Body Photography
  42. Participant Motivators and Expectations in the MEL-SELF Randomized Clinical Trial of Patient-Led Surveillance for Recurrent Melanoma: Content Analysis of Survey Responses (Preprint)
  43. Working together to improve type 2 diabetes care: a Participatory Design project to address identified needs of people with diabetes and their healthcare professionals
  44. Balancing the risks and benefits of sun exposure: A revised position statement for Australian adults
  45. Re: Incidence of in situ vs invasive melanoma: testing the “obligate precursor” hypothesis
  46. Learnings from implementing a surgical training program
  47. Pre-post feasibility trial of a telephone-delivered exercise intervention for patients during chemotherapy for recurrent ovarian cancer: the ECHO-R trial protocol
  48. Implementation of Patient-Reported Outcomes in a Medical Oncology Setting (the iPROMOS Study): Type II Hybrid Implementation Study (Preprint)
  49. Melanoma screening workshop summary report
  50. Skin cancer awareness in the personal services industry
  51. Skin Cancer Prevention Queensland: Sunscreen Industry Forum Report
  52. Feasibility and safety of a surgical training program in total laparoscopic hysterectomy: Results of a pilot trial
  53. Position statement: balancing the harms and benefits of sun exposure
  54. Spatial Randomness in the Distribution of Acquired Melanocytic Nevi of the Back in a Population-Based Sample
  55. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals—a cluster randomised controlled trial
  56. Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial
  57. Sun Exposure Summit position statement
  58. Consumer views of melanoma early detection using 3D total‐body photography: cross‐sectional survey
  59. Skin Cancer Prevention Queensland: towards a future of reduced skin cancer burden for Queenslanders
  60. Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
  61. The dynamic nature of naevi in adulthood: prospective population-based study using three-dimensional total-body photography
  62. Informing a position statement on the use of artificial intelligence in dermatology in Australia
  63. Consumer perceptions on privacy and confidentiality in dermatology for 3D total‐body imaging
  64. Can people take high‐quality images using mobile dermatoscopes at home on easy‐to‐see and difficult‐to‐see body areas?
  65. Body Site Distribution of Acquired Melanocytic Naevi and Associated Characteristics in the General Population of Caucasian Adults: A Scoping Review
  66. Toward Incorporating Health-Related Quality of Life as Coprimary End Points in Clinical Trials: Time to Achieve Clinical Important Differences and QoL Profiles
  67. Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study
  68. Perspectives and experiences of patient-led melanoma surveillance using digital technologies from clinicians involved in the MEL-SELF pilot randomised controlled trial: Qualitative Interview Study (Preprint)
  69. A qualitative analysis of the needs and wishes of people with type 2 diabetes and healthcare professionals for optimal diabetes care
  70. Experience from an outright ban of commercial sunbeds in the Australian context
  71. Digital Technology in Skin Cancer Prevention and Early Detection
  72. Digital Technology in Skin Cancer Prevention and Early Detection (Preprint)
  73. Reasons behind Low Cervical Screening Uptake among South Asian Immigrant Women: A Qualitative Exploration
  74. Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study (Preprint)
  75. Factors influencing participants’ engagement with an interactive text-message intervention to improve sun protection behaviors: “SunText” randomized controlled trial
  76. Consumer Preference and Willingness to Pay for Direct-to-Consumer Mobile Teledermoscopy Services in Australia
  77. The Additive Value of 3D Total Body Imaging for Sequential Monitoring of Skin Lesions: A Case Series
  78. Describing the Skin Surface Ecosystem Using 3D Total Body Photography
  79. Anatomic Distribution of Cherry Angiomas in the General Population
  80. Reproducible Naevus Counts Using 3D Total Body Photography and Convolutional Neural Networks
  81. The impact on health outcomes of implementing electronic health records to support the care of older people in residential aged care: A scoping review
  82. Review of educational tools for skin self‐examination: A qualitative analysis of laypeople’s preferences
  83. Weight and weight control behaviors during long‐term endometrial cancer survivorship: Results of the Laparoscopic Approach to Cancer of the Endometrium long‐term follow‐up study
  84. High variability in anatomic patterns of cutaneous photodamage: a population‐based study
  85. Development of a Checklist Tool to Assess the Quality of Skin Lesion Images Acquired by Consumers Using Sequential Mobile Teledermoscopy
  86. Clinical utility of skin cancer and melanoma risk scores for population screening: TRoPICS study
  87. The Importance of Incorporating Human Factors in the Design and Implementation of Artificial Intelligence for Skin Cancer Diagnosis in the Real World
  88. Changes in cancer preventive behaviours, screening and diagnosis during COVID‐19
  89. Review of smartphone mobile applications for skin cancer detection: what are the changes in availability, functionality, and costs to users over time?
  90. Quality of life following minimally invasive hysterectomy compared to abdominal hysterectomy: A metanalysis
  91. Incidence and risk factors for lower limb lymphedema associated with endometrial cancer: Results from a prospective, longitudinal cohort study.
  92. Fertility-sparing treatment in early endometrial cancer: current state and future strategies
  93. Virtual melanoma checks during a pandemic
  94. Practice guidelines for teledermatology in Australia
  95. Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre Melanoma Screening Summit
  96. A review of literature supporting the development of practice guidelines for teledermatology in Australia
  97. The use of CAM products, practices, and practitioners by long-term endometrial cancer survivors in Australia
  98. Consumer skin cancer screening preferences
  99. Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial
  100. Long‐term deaths from melanoma according to tumor thickness at diagnosis
  101. Tweets about sunburn
  102. Prevention versus early detection for long-term control of melanoma and keratinocyte carcinomas: a cost-effectiveness modelling study
  103. Self‐reported naevus density may lead to misclassification of melanoma risk
  104. Using Mobile Health Technology and Social Media for the Prevention and Early Detection of Skin Cancer
  105. Is Teledermoscopy Ready to Replace Face-to-Face Examinations for the Early Detection of Skin Cancer? Consumer Views, Technology Acceptance, and Satisfaction with Care
  106. What Can Twitter Tell Us about Skin Cancer Communication and Prevention on Social Media?
  107. Factors in Randomized Controlled Trials Reported to Impact the Implementation of Patient-Reported Outcome Measures Into Routine Care: Protocol for a Systematic Review
  108. Unintended sunburn after applying sunscreen
  109. 3D Total Body Photography for early melanoma detection
  110. What is needed by staff to implement PROMs into routine oncology care? A qualitative study with the multi‐disciplinary team
  111. Multidisciplinary cancer care in Australia
  112. UV detection stickers can assist people to reapply sunscreen
  113. Is there a role for digital technology in measuring the value of skin self‐examination?
  114. Factors in Randomized Controlled Trials Reported to Impact the Implementation of Patient-Reported Outcome Measures Into Routine Care: Protocol for a Systematic Review (Preprint)
  115. How to train practising gynaecologists in total laparoscopic hysterectomy: protocol for the stepped-wedge IMAGINE trial
  116. Patient-Reported Experiences After Hysterectomy: A Cross-Sectional Study of the Views of Over 2300 Women
  117. Patient Portals Facilitating Engagement With Inpatient Electronic Medical Records: A Systematic Review
  118. Can clinical decision making be enhanced by artificial intelligence?
  119. Challenges and controversies in the conservative management of uterine and ovarian cancer
  120. How many patients enter endometrial cancer surgery with psychotropic medication prescriptions, and how many receive a new prescription perioperatively?
  121. The iPROMOS protocol: a stepped-wedge study to implement routine patient-reported outcomes in a medical oncology outpatient setting
  122. Evaluating healthcare practitioners’ views on store-and-forward teledermoscopy services for the diagnosis of skin cancer
  123. Sun protection behavior after diagnosis of high-risk primary melanoma and risk of a subsequent primary
  124. A Mobile Technology Intervention With Ultraviolet Radiation Dosimeters and Smartphone Apps for Skin Cancer Prevention in Young Adults: Randomized Controlled Trial
  125. Patient Portals Facilitating Engagement With Inpatient Electronic Medical Records: A Systematic Review (Preprint)
  126. Consumer Acceptance and Expectations of a Mobile Health Application to Photograph Skin Lesions for Early Detection of Melanoma
  127. Redesigning Skin Cancer Early Detection and Care Using a New Mobile Health Application: Protocol of the SKIN Research Project, a Randomised Controlled Trial
  128. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis
  129. Fighting Melanoma with Smartphones: A Snapshot of Where We are a Decade after App Stores Opened Their Doors
  130. Using Advances in Skin Imaging Technology and Genomics for the Early Detection and Prevention of Melanoma
  131. Why a randomized melanoma screening trial may be a good idea
  132. ‘Mind your Moles’ study: protocol of a prospective cohort study of melanocytic naevi
  133. Obesity in total laparoscopic hysterectomy for early stage endometrial cancer: health gain and inpatient resource use
  134. Are psychological interventions effective on anxiety in cancer patients? A systematic review and meta-analyses
  135. All-cause death in young women with endometrial cancer who receive progesterone therapy
  136. Capturing Ultraviolet Radiation Exposure and Physical Activity: Feasibility Study and Comparison Between Self-Reports, Mobile Apps, Dosimeters, and Accelerometers
  137. Pelvic floor functional outcomes after total abdominal vs total laparoscopic hysterectomy for endometrial cancer
  138. Chemotherapy in patients with unresected pancreatic cancer in Australia: A population-based study of uptake and survival
  139. A Mobile Technology Intervention With Ultraviolet Radiation Dosimeters and Smartphone Apps for Skin Cancer Prevention in Young Adults: Randomized Controlled Trial (Preprint)
  140. Clinical trials, culture and language: More than meets the eye?
  141. Effect of solar ultraviolet radiation exposure on serum 25(OH)D concentration: a pilot randomised controlled trial
  142. Capturing Ultraviolet Radiation Exposure and Physical Activity: Feasibility Study and Comparison Between Self-Reports, Mobile Apps, Dosimeters, and Accelerometers (Preprint)
  143. Psychological distress among Indigenous Australian cancer survivors
  144. Time and treatments: It is what you make of it that counts
  145. Do hand-addressed envelopes improve community response rates for a longitudinal study?
  146. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors
  147. The validity and reliability of remote diabetic foot ulcer assessment using mobile phone images
  148. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years
  149. Nutrition interventions in patients with gynecological cancers requiring surgery
  150. Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer
  151. Anxiety, depression and quality of life in people with pancreatic cancer and their carers
  152. Efficacy of smartphone applications in high-risk pigmented lesions
  153. The Living Well after Breast Cancer™ Pilot Trial: a weight loss intervention for women following treatment for breast cancer
  154. Greater Precision in Melanoma Prevention
  155. Factors associated with quality of care for patients with pancreatic cancer in Australia
  156. Living well after breast cancer randomized controlled trial protocol: evaluating a telephone-delivered weight loss intervention versus usual care in women following treatment for breast cancer
  157. A Randomized Trial on the Effect of Exercise Mode on Breast Cancer–Related Lymphedema
  158. Consumer teledermoscopy for melanoma diagnosis
  159. Can skin cancer prevention be improved through mobile technology interventions? A systematic review
  160. Determinants of survival and attempted resection in patients with non-metastatic pancreatic cancer: An Australian population-based study
  161. Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up study
  162. Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case-control study
  163. Economics of teledermatology
  164. Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study
  165. Determinants of Outcomes Following Resection for Pancreatic Cancer—a Population-Based Study
  166. Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study
  167. Erratum to: QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
  168. Self-Reported Changes in Sun-Protection Behaviors at Different Latitudes in Australia
  169. Compression use during an exercise intervention and associated changes in breast cancer-related lymphedema
  170. Health-related quality of life among Indigenous Australians diagnosed with cancer
  171. Estimating Skin Cancer Risk: Evaluating Mobile Computer-Adaptive Testing
  172. Using a Delphi process to determine optimal care for patients with pancreatic cancer
  173. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30
  174. A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients
  175. Mediation of improvements in sun protective and skin self-examination behaviours: results from the healthy text study
  176. Beyond survivorship? A discursive analysis of how people with pancreatic cancer negotiate identity transitions in their health
  177. A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services
  178. Review of the Evidence of Lymphedema Treatment Effect
  179. Quality of life after early enteral feeding versus standard care for proven or suspected advanced epithelial ovarian cancer: Results from a randomised trial
  180. Consumer preferences for teledermoscopy screening to detect melanoma early
  181. Psychometric properties of an Australian supportive care needs assessment tool for Indigenous patients with cancer
  182. Redefining Dermatologists’ Role in Skin Cancer Early Detection and Follow-up Care
  183. Lower preoperative quality of life increases postoperative risk of adverse events in women with endometrial cancer: Results from the LACE trial
  184. Consumer Teledermoscopy
  185. Incidence, Risk Factors, and Estimates of a Woman’s Risk for Developing Secondary Lower Limb Lymphedema and Lymphedema-Specific Supportive Care Needs in Women Treated for Endometrial Cancer
  186. Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population
  187. User preferences for text message-delivered skin cancer prevention and early detection
  188. Can skin cancer prevention and early detection be improved via mobile phone text messaging? A randomised, attention control trial
  189. Women with self-reported lower-limb lymphedema after treatment for gynecological cancers: are they more likely to self-report psychosocial symptoms and less likely to use services?
  190. Systematic Review of Interventions to Improve the Provision of Information for Adults with Primary Brain Tumors and Their Caregivers
  191. Exercise barriers self-efficacy: development and validation of a subcale for individuals with cancer-related lymphedema
  192. Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer
  193. Women’s Perceptions of Their Lifestyle and Quality of Life Several Years After a Diagnosis of Endometrial Cancer
  194. Evaluation of a skin self examination attitude scale using an item response theory model approach
  195. Prevalence, predictors, and correlates of supportive care needs among women 3–5 years after a diagnosis of endometrial cancer
  196. Changes in Outdoor Workersʼ Sun-Related Attitudes, Beliefs, and Behaviors
  197. Improving treatment for obese women with early stage cancer of the uterus: Rationale and design of the levonorgestrel intrauterine device±Metformin±weight loss in endometrial cancer (feMME) trial
  198. Primary Prevention of Skin Cancer
  199. Lesion Selection by Melanoma High-Risk Consumers During Skin Self-examination Using Mobile Teledermoscopy
  200. Quality of life of women with lower limb swelling or lymphedema 3–5years following endometrial cancer
  201. Clinical Skin Examination Outcomes After a Video-Based Behavioral Intervention
  202. Uptake of Skin Self-examination and Clinical Examination Behavior by Outdoor Workers
  203. Mobile Medical Applications for Melanoma Risk Assessment: False Assurance or Valuable Tool?
  204. Teledermatology: Its Use in the Detection and Management of Actinic Keratosis
  205. Interventions to decrease skin cancer risk in outdoor workers: update to a 2007 systematic review
  206. Serum HE4 as a prognostic marker in endometrial cancer — A population based study
  207. Skin cancer detection by one click — are we any closer?
  208. Epidural analgesia is associated with an increased incidence of postoperative complications in patients requiring an abdominal hysterectomy for early stage endometrial cancer
  209. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer-A population-based data linkage study
  210. An Instrument to Measure Adherence to Weight Loss Programs: The Compliance Praxis Survey-Diet (COMPASS-Diet)
  211. Identification of doctors at risk of recurrent complaints: a national study of healthcare complaints in Australia
  212. Advances in Skin Cancer Early Detection and Diagnosis
  213. The HealthyTexts study: A randomized controlled trial to improve skin cancer prevention behaviors among young people
  214. Determinants of Uptake of Whole-Body Skin Self-Examination in Older Men
  215. Nomogram to Predict the Probability of Relapse in Patients Diagnosed With Borderline Ovarian Tumors
  216. Enhanced Skin Self-examination: A Novel Approach to Skin Cancer Monitoring and Follow-up
  217. The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer
  218. Differences in Epidural and Analgesic Use in Patients with Apparent Stage I Endometrial Cancer Treated by Open versus Laparoscopic Surgery: Results from the Randomised LACE Trial
  219. Predicting positive and negative impacts of cancer among long-term endometrial cancer survivors
  220. Health professionals' perspectives on information provision for patients with brain tumours and their families
  221. Risk factors to predict the incidence of surgical adverse events following open or laparoscopic surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial
  222. Quality and Readability of Information Materials for People with Brain Tumours and Their Families
  223. How people construct their experience of living with secondary lymphoedema in the context of their everyday lives in Australia
  224. Characteristics of men aged 50 years or older who do not take up skin self-examination following an educational intervention
  225. Improved surgical safety after laparoscopic compared to open surgery for apparent early stage endometrial cancer: Results from a randomised controlled trial
  226. The Children and Sunscreen Study
  227. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: A meta-analysis and systematic review of the literature
  228. Possible Genetic Predisposition to Lymphedema after Breast Cancer
  229. Development and piloting of a brain tumour-specific question prompt list
  230. Personalised electronic messages to improve sun protection in young adults
  231. The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer
  232. Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study
  233. Lymphedema After Breast or Gynecological Cancer: Use and Effectiveness of Mainstream and Complementary Therapies
  234. Impact of a Video-Based Intervention to Improve the Prevalence of Skin Self-examination in Men 50 Years or Older
  235. Quality of life of women with lower-limb lymphedema following gynecological cancer
  236. Body-site distribution of skin cancer, pre-malignant and common benign pigmented lesions excised in general practice
  237. Factors associated with recall of media reports about vitamin D and sun protection
  238. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma
  239. In Vitro Model of Vitamin D Synthesis by UV Radiation in an Australian Urban Environment
  240. Laparoscopy or laparotomy for early endometrial cancer? – Authors' reply
  241. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): a randomised trial
  242. Patterns, correlates, and prognostic significance of quality of life following breast cancer
  243. Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: A community-based project in a rural setting
  244. Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study
  245. Knowledge about health benefits of vitamin D in Queensland Australia
  246. Seasonal Variation in Measured Solar Ultraviolet Radiation Exposure of Adults in Subtropical Australia
  247. The skin awareness study: Promoting thorough skin self-examination for skin cancer among men 50years or older
  248. Does quality of life among breast cancer survivors one year after diagnosis differ depending on urban and non-urban residence? A comparative study
  249. Gynecological cancer survivors and community support services: referral, awareness, utilization and satisfaction
  250. What determines the health‐related quality of life among regional and rural breast cancer survivors?
  251. Depression, anxiety and body image after treatment for invasive stage one epithelial ovarian cancer
  252. Recruiting older adults to health research studies: A systematic review
  253. Lymphedema Following Breast Cancer
  254. Vitamin D and sun protection: The impact of mixed public health messages in Australia
  255. Views of supervisors of colonoscopy training on quality issues for the national bowel cancer screening program in Australia
  256. Factors Associated With the Number of Lesions Excised for Each Skin Cancer
  257. The Queensland cancer risk study: general population norms for the Functional Assessment of Cancer Therapy–General (FACT‐G)
  258. Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma
  259. Treatment for upper-limb and lower-limb lymphedema by professionals specializing in lymphedema care
  260. Lymphedema After Breast Cancer: Incidence, Risk Factors, and Effect on Upper Body Function
  261. Unmet supportive care needs and interest in services among patients with a brain tumour and their carers
  262. Gynecological cancer survivors’ health behaviors and their associations with quality of life
  263. Health-related quality of life 18 months after breast cancer: comparison with the general population of Queensland, Australia
  264. Elderly patients with stage III or IV ovarian cancer: should they receive standard care?
  265. Quality of life among patients with a brain tumor and their carers
  266. Medical cost-offsets from psychosocial care in breast cancer
  267. Sun protection and low levels of vitamin D: are people concerned?
  268. The effect of an educational programme to improve the skills of general practitioners in diagnosing melanocytic/pigmented lesions
  269. Lymphedema after gynecological cancer treatment
  270. Diagnosis and management costs of suspicious skin lesions from a population-based melanoma screening programme
  271. Malnutrition among gynaecological cancer patients
  272. Reply
  273. What motivates men age ≥ 50 years to participate in a screening program for melanoma?
  274. Total laparoscopic versus open surgery for stage 1 endometrial cancer: The LACE randomized controlled trial
  275. Supportive care needs of people with brain tumours and their carers
  276. Do Centralised Skin Screening Clinics Increase Participation in Melanoma Screening (Australia)?
  277. Clinical outcomes from skin screening clinics within a community-based melanoma screening program
  278. Who attends skin cancer clinics within a randomized melanoma screening program?
  279. Voluntary whole-blood donors, and compensated platelet donors and plasma donors: Motivation to donate, altruism and aggression
  280. Increase in skin cancer screening during a community-based randomized intervention trial
  281. The functional assessment of cancer-vulvar: Reliability and validity
  282. Acceptability and feasibility of a community-based screening programme for melanoma in Australia
  283. Comparability of Skin Screening Histories Obtained by Telephone Interviews and Mailed Questionnaires: A Randomized Crossover Study
  284. The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT
  285. Primary prevention of skin cancer: a review of sun protection in Australia and internationally
  286. Vulvar cancer patients' quality of life: a qualitative assessment
  287. Attitudes and intentions in relation to skin checks for early signs of skin cancer
  288. Prevalence of Whole-Body Skin Self-Examination in a Population at High Risk for Skin Cancer (Australia)
  289. Validity of Self-reported Skin Screening Histories
  290. Impaired Quality of Life in Patients Commencing Radiotherapy for Cancer
  291. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: Effect on progression-free survival
  292. Acute Side Effects during 3-D-Planned Conformal Radiotherapy of Prostate Cancer
  293. Impact of Videotaped Information on Frequency and Confidence of Breast Self-Examination
  294. Measurement of Quality of Life in Head and Neck Cancer Patients Utilizing the Quality of Life Radiation Therapy Questionnaire
  295. Primary fallopian tube carcinoma: the Queensland experience
  296. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma
  297. Quality of life changes during conformal radiation therapy for prostate carcinoma